Nephritic syndrome: Difference between revisions
Ostermayer (talk | contribs) (Created page with "Nephritic syndrome is a clinical syndrome resulting from '''glomerular inflammation (glomerulonephritis)''', characterized by '''hematuria''' (with dysmorphic RBCs and RBC casts), '''hypertension''', '''oliguria''', '''edema''', and '''subnephrotic proteinuria'''.<ref name="StatPearls">Nephritic Syndrome. ''StatPearls''. NCBI. 2023.</ref> It is distinguished from Nephrotic syndrome primarily by the presence of '''hematuria and active urinary sediment'''. The EM physi...") |
(Moved intro paragraph into Background section as bullets; removed excessive bold from bullet lead-ins throughout; added Glomerulonephritis causes and Hyperkalemia DDX template transclusions; bold retained only for critical items) |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Nephritic syndrome is a clinical syndrome resulting from glomerular inflammation (glomerulonephritis), characterized by hematuria (with dysmorphic RBCs and RBC casts), hypertension, oliguria, edema, and subnephrotic proteinuria<ref name="StatPearls">Nephritic Syndrome. ''StatPearls''. NCBI. 2023.</ref> | |||
*It is distinguished from [[Nephrotic syndrome]] primarily by the presence of hematuria and active urinary sediment | |||
*The EM physician encounters nephritic syndrome as "cola-colored" urine in a child 1-3 weeks after a sore throat (post-streptococcal GN), acute renal failure with hypertension and pulmonary edema, or hemoptysis with renal failure (pulmonary-renal syndrome) | |||
*The key ED tasks are to recognize the syndrome via urinalysis, manage life-threatening complications (hypertensive emergency, hyperkalemia, pulmonary edema, AKI), identify '''rapidly progressive glomerulonephritis (RPGN)''' as a true emergency requiring immediate nephrology involvement, and initiate targeted serologic workup | |||
*Nephritic syndrome is a '''pattern of glomerular disease''', not a single diagnosis — many diseases present this way | *Nephritic syndrome is a '''pattern of glomerular disease''', not a single diagnosis — many diseases present this way | ||
* | * Children: post-streptococcal glomerulonephritis (PSGN) is the most common cause | ||
* | * Adults: IgA nephropathy, lupus nephritis, ANCA-associated vasculitis, and infection-associated GN are more common | ||
*The distinction between nephritic and nephrotic syndromes is fundamental to the ED evaluation of renal disease: | *The distinction between nephritic and nephrotic syndromes is fundamental to the ED evaluation of renal disease: | ||
| Line 34: | Line 36: | ||
==Clinical features== | ==Clinical features== | ||
===Classic acute nephritic syndrome=== | ===Classic acute nephritic syndrome=== | ||
* | * Hematuria "cola-colored," "tea-colored," or "smoky" urine (gross hematuria); or microscopic hematuria | ||
* | * Edema periorbital (especially on waking), lower extremity; mild to moderate | ||
* | * Hypertension from sodium/water retention and intravascular volume expansion; may be '''severe''' | ||
* | * Oliguria reduced urine output (<400 mL/day in adults; <0.5 mL/kg/hr in children) | ||
* | * Proteinuria present but usually subnephrotic | ||
* | * Malaise, fatigue, anorexia, nausea | ||
* | * Flank or abdominal pain (especially in children) | ||
*Onset is often '''abrupt''' (days to 1-2 weeks) | *Onset is often '''abrupt''' (days to 1-2 weeks) | ||
===Post-streptococcal glomerulonephritis (PSGN) — the prototype=== | ===Post-streptococcal glomerulonephritis (PSGN) — the prototype=== | ||
* | * Most common cause in children (ages 5-12 years); declining incidence in developed countries<ref name="GN">Glomerulonephritis. ''StatPearls''. NCBI. 2023.</ref> | ||
* | * Latent period 1-2 weeks after pharyngitis; 3-6 weeks after skin infection (pyoderma/impetigo) | ||
* | * Not present during the infection — symptoms appear after a latent period (distinguishes from IgA nephropathy, which is synpharyngitic) | ||
* | * Gross hematuria in >50% of cases; "smoky" or "cola-colored" urine | ||
* | * Edema and hypertension from salt/water retention | ||
* | * Low C3 complement (returns to normal within 6-8 weeks — failure to normalize suggests MPGN or C3 glomerulopathy) | ||
*Usually '''self-limited''' in children (>95% recover completely); adults have worse prognosis | *Usually '''self-limited''' in children (>95% recover completely); adults have worse prognosis | ||
===IgA nephropathy (Berger disease) — the most common GN worldwide=== | ===IgA nephropathy (Berger disease) — the most common GN worldwide=== | ||
* | * Synpharyngitic hematuria: gross hematuria occurring '''within 1-2 days''' of an upper respiratory infection (NOT after a latent period — key distinction from PSGN)<ref name="Wiki_Neph">Nephritic syndrome. ''Wikipedia''. 2025.</ref> | ||
*Recurrent episodes of gross hematuria | *Recurrent episodes of gross hematuria | ||
*Between episodes: persistent microscopic hematuria ± proteinuria | *Between episodes: persistent microscopic hematuria ± proteinuria | ||
* | * Normal complement levels (unlike PSGN) | ||
*May overlap with [[Henoch-Schönlein purpura]] (IgA vasculitis) — systemic form with palpable purpura, arthritis, abdominal pain, and GN | *May overlap with [[Henoch-Schönlein purpura]] (IgA vasculitis) — systemic form with palpable purpura, arthritis, abdominal pain, and GN | ||
===Rapidly progressive glomerulonephritis (RPGN) — the EM emergency=== | ===Rapidly progressive glomerulonephritis (RPGN) — the EM emergency=== | ||
* | * Defines >50% loss of renal function within 3 months | ||
*Nephritic sediment + '''rapidly rising creatinine''' over days to weeks | *Nephritic sediment + '''rapidly rising creatinine''' over days to weeks | ||
*Pathologic hallmark: '''crescent formation''' in glomeruli on biopsy | *Pathologic hallmark: '''crescent formation''' in glomeruli on biopsy | ||
* | * Three immunologic categories: | ||
{| class="wikitable" | {| class="wikitable" | ||
| Line 89: | Line 91: | ||
====Low C3 (hypocomplementemic)==== | ====Low C3 (hypocomplementemic)==== | ||
* | * Post-streptococcal GN (low C3; C4 normal or slightly low; normalizes by 6-8 weeks) | ||
* | * Lupus nephritis (low C3 AND C4) | ||
* | * MPGN / C3 glomerulopathy (persistently low C3) | ||
* | * Endocarditis-associated GN (low C3; blood cultures positive) | ||
* | * Cryoglobulinemic GN (low C3 and C4; hepatitis C associated) | ||
====Normal complement==== | ====Normal complement==== | ||
* | * IgA nephropathy | ||
* | * ANCA-associated vasculitis (GPA, MPA) | ||
* | * Anti-GBM disease (Goodpasture) | ||
* | * Henoch-Schönlein purpura | ||
* | * Hereditary nephritis (Alport syndrome) | ||
===Non-glomerular causes of hematuria to exclude=== | ===Non-glomerular causes of hematuria to exclude=== | ||
* | * Urinary tract infection (positive urine culture; normal RBC morphology) | ||
* | * Nephrolithiasis (flank pain; isomorphic RBCs; no casts) | ||
* | * Trauma | ||
* | * Urologic malignancy (adults; painless hematuria) | ||
* | * Menstrual contamination | ||
* | * Exercise-induced hematuria | ||
===Key to glomerular vs non-glomerular hematuria=== | ===Key to glomerular vs non-glomerular hematuria=== | ||
* | * Glomerular dysmorphic RBCs (acanthocytes), '''RBC casts''' (virtually pathognomonic), proteinuria, brown/cola-colored urine, no clots | ||
* | * Non-glomerular normal/isomorphic RBCs, no casts, pink/red urine, may have clots | ||
{{Glomerulonephritis causes}} | |||
{{Hyperkalemia DDX}} | |||
==Evaluation== | ==Evaluation== | ||
===ED workup=== | ===ED workup=== | ||
* | * Urinalysis with microscopy the '''single most important test'''<ref name="AcuteGN">Acute Glomerulonephritis Workup. ''Medscape''. 2024.</ref> | ||
** | ** RBC casts: virtually pathognomonic for glomerulonephritis | ||
** | ** Dysmorphic RBCs (acanthocytes — best seen with phase-contrast microscopy; >30% dysmorphic is highly specific for glomerular origin) | ||
**Proteinuria (usually 1-3+ on dipstick) | **Proteinuria (usually 1-3+ on dipstick) | ||
**Sterile pyuria (WBCs without bacteria) | **Sterile pyuria (WBCs without bacteria) | ||
* | * BMP/CMP: | ||
** | ** Creatinine (elevated = impaired GFR; trending creatinine is critical for identifying RPGN) | ||
** | ** Potassium (hyperkalemia from impaired excretion — potentially life-threatening) | ||
** | ** Bicarbonate (metabolic acidosis) | ||
** | ** BUN (elevated; disproportionately elevated BUN:creatinine ratio in prerenal azotemia) | ||
* | * CBC anemia (dilutional or from chronic disease); thrombocytopenia (TTP-HUS, SLE) | ||
* | * Spot urine protein:creatinine ratio: quantifies proteinuria; helps distinguish nephritic (<3.5) from nephrotic (>3.5) | ||
* | * Albumin usually near-normal (mildly low at most); if markedly low, consider nephrotic overlap | ||
* | * Blood pressure frequently elevated; may be severely hypertensive | ||
===Targeted serologic workup (initiate from ED based on clinical suspicion)=== | ===Targeted serologic workup (initiate from ED based on clinical suspicion)=== | ||
| Line 158: | Line 164: | ||
===Imaging=== | ===Imaging=== | ||
* | * Renal ultrasound assess kidney size (normal or enlarged in acute GN; small in chronic GN), exclude obstruction | ||
* | * Chest X-ray if dyspnea (pulmonary edema, pulmonary hemorrhage/DAH), cough, hemoptysis | ||
* | * CT head if hypertensive encephalopathy suspected (altered mental status, seizures, visual changes) | ||
* | * Echocardiography if endocarditis suspected | ||
===Renal biopsy=== | ===Renal biopsy=== | ||
* | * Not an ED procedure — arranged by nephrology | ||
*Indicated for most adults with nephritic syndrome (PSGN in children with typical presentation usually does not require biopsy) | *Indicated for most adults with nephritic syndrome (PSGN in children with typical presentation usually does not require biopsy) | ||
* | * Urgent biopsy indications: suspected RPGN, rapidly deteriorating renal function, unclear diagnosis | ||
==Management== | ==Management== | ||
| Line 173: | Line 179: | ||
====Hypertensive emergency==== | ====Hypertensive emergency==== | ||
*May present with '''encephalopathy, seizures, visual changes, pulmonary edema''' | *May present with '''encephalopathy, seizures, visual changes, pulmonary edema''' | ||
* | * Salt and water restriction | ||
* | * Loop diuretics furosemide 1-2 mg/kg IV (children) or 40-80 mg IV (adults) — first-line for volume-overload hypertension | ||
* | * IV antihypertensives if diuretics insufficient: nicardipine infusion, labetalol, or hydralazine | ||
*Avoid ACE inhibitors/ARBs in the '''acute''' setting with AKI and hyperkalemia (may worsen both) | *Avoid ACE inhibitors/ARBs in the '''acute''' setting with AKI and hyperkalemia (may worsen both) | ||
*Target: gradual reduction; do not lower BP >25% in the first hour | *Target: gradual reduction; do not lower BP >25% in the first hour | ||
====Hyperkalemia==== | ====Hyperkalemia==== | ||
* | * Impaired renal excretion → dangerous hyperkalemia | ||
*Manage per standard [[Hyperkalemia]] protocols: calcium gluconate (cardiac membrane stabilization), insulin + dextrose, albuterol, sodium bicarbonate, kayexalate/patiromer, dialysis if refractory | *Manage per standard [[Hyperkalemia]] protocols: calcium gluconate (cardiac membrane stabilization), insulin + dextrose, albuterol, sodium bicarbonate, kayexalate/patiromer, dialysis if refractory | ||
====Pulmonary edema / volume overload==== | ====Pulmonary edema / volume overload==== | ||
* | * IV furosemide (high-dose may be needed with impaired GFR) | ||
* | * Oxygen, positive pressure ventilation (CPAP/BiPAP or intubation) if severe | ||
* | * Fluid and sodium restriction | ||
* | * Dialysis if refractory pulmonary edema unresponsive to diuretics | ||
====Pulmonary hemorrhage (pulmonary-renal syndrome)==== | ====Pulmonary hemorrhage (pulmonary-renal syndrome)==== | ||
* | * ICU admission | ||
* | * Urgent nephrology and pulmonology consultation | ||
* | * Plasma exchange (plasmapheresis): especially for anti-GBM disease (removes pathogenic antibodies) | ||
* | * Pulse IV methylprednisolone (1 g daily for 3 days) ± cyclophosphamide — initiated by specialist | ||
* | * Intubation and mechanical ventilation if significant hemorrhage/respiratory failure | ||
* | * Type and crossmatch — transfuse for significant anemia from hemorrhage | ||
===General ED management of acute nephritic syndrome=== | ===General ED management of acute nephritic syndrome=== | ||
* | * Fluid restriction limit to insensible losses + urine output | ||
* | * Sodium restriction | ||
* | * Loop diuretics for edema and hypertension | ||
* | * Monitor urine output, blood pressure, electrolytes (especially potassium), creatinine q6-12 hours | ||
* | * Treat underlying infection: antibiotics for endocarditis; note that PSGN treatment targets the ''complication'' (not the strep infection itself — the GN is post-infectious; antibiotics do not alter the course of GN but may eradicate ongoing streptococcal infection) | ||
* | * Hold nephrotoxic medications: NSAIDs, aminoglycosides, contrast dye | ||
===Disease-specific treatment (nephrology-directed)=== | ===Disease-specific treatment (nephrology-directed)=== | ||
* | * PSGN supportive care; usually self-limited; antibiotics only to eradicate residual streptococcal infection | ||
* | * Lupus nephritis corticosteroids ± mycophenolate mofetil or cyclophosphamide | ||
* | * ANCA-associated vasculitis pulse steroids + cyclophosphamide or rituximab; plasma exchange for severe disease | ||
* | * Anti-GBM disease plasma exchange + steroids + cyclophosphamide — '''true emergency; outcomes are time-dependent''' | ||
* | * IgA nephropathy ACE inhibitor/ARB; immunosuppression for severe/progressive disease | ||
* | * Endocarditis-associated GN treat the endocarditis; immunosuppression is '''contraindicated''' (would worsen infection) | ||
==Disposition== | ==Disposition== | ||
* | * Admit: | ||
**Hypertensive emergency or severely elevated blood pressure | **Hypertensive emergency or severely elevated blood pressure | ||
**Hyperkalemia | **Hyperkalemia | ||
| Line 222: | Line 228: | ||
**Significant AKI (creatinine >2x baseline, oliguria, need for dialysis) | **Significant AKI (creatinine >2x baseline, oliguria, need for dialysis) | ||
**New-onset nephritic syndrome in adults (most require biopsy and specialist evaluation) | **New-onset nephritic syndrome in adults (most require biopsy and specialist evaluation) | ||
* | * Consider discharge with close follow-up (48-72 hours): | ||
**Child with classic PSGN presentation: mild edema + mild hypertension + stable renal function + no hyperkalemia + confirmed strep history | **Child with classic PSGN presentation: mild edema + mild hypertension + stable renal function + no hyperkalemia + confirmed strep history | ||
**Ensure '''nephrology or pediatric nephrology follow-up''' within 48-72 hours | **Ensure '''nephrology or pediatric nephrology follow-up''' within 48-72 hours | ||
**Return precautions: decreased urine output, worsening edema, headache, visual changes, seizures, difficulty breathing | **Return precautions: decreased urine output, worsening edema, headache, visual changes, seizures, difficulty breathing | ||
* | * Always obtain nephrology consultation for: RPGN, pulmonary-renal syndrome, unclear diagnosis, adults with nephritic syndrome, renal failure requiring dialysis | ||
==See Also== | ==See Also== | ||
Revision as of 12:51, 19 March 2026
Background
- Nephritic syndrome is a clinical syndrome resulting from glomerular inflammation (glomerulonephritis), characterized by hematuria (with dysmorphic RBCs and RBC casts), hypertension, oliguria, edema, and subnephrotic proteinuria[1]
- It is distinguished from Nephrotic syndrome primarily by the presence of hematuria and active urinary sediment
- The EM physician encounters nephritic syndrome as "cola-colored" urine in a child 1-3 weeks after a sore throat (post-streptococcal GN), acute renal failure with hypertension and pulmonary edema, or hemoptysis with renal failure (pulmonary-renal syndrome)
- The key ED tasks are to recognize the syndrome via urinalysis, manage life-threatening complications (hypertensive emergency, hyperkalemia, pulmonary edema, AKI), identify rapidly progressive glomerulonephritis (RPGN) as a true emergency requiring immediate nephrology involvement, and initiate targeted serologic workup
- Nephritic syndrome is a pattern of glomerular disease, not a single diagnosis — many diseases present this way
- Children: post-streptococcal glomerulonephritis (PSGN) is the most common cause
- Adults: IgA nephropathy, lupus nephritis, ANCA-associated vasculitis, and infection-associated GN are more common
- The distinction between nephritic and nephrotic syndromes is fundamental to the ED evaluation of renal disease:
| Feature | Nephritic syndrome | Nephrotic syndrome |
|---|---|---|
| Primary mechanism | Glomerular inflammation | Podocyte injury (permeability defect) |
| Hematuria | Prominent (dysmorphic RBCs, RBC casts) | Absent or minimal |
| Proteinuria | Subnephrotic (<3.5 g/day) | Nephrotic-range (>3.5 g/day) |
| Edema | Mild-moderate (volume overload) | Severe (hypoalbuminemia) |
| Hypertension | Prominent (salt/water retention) | Variable |
| Serum albumin | Normal or mildly low | Markedly low (<3.0 g/dL) |
| Hyperlipidemia | Absent | Present |
| Urine sediment | Active: RBC casts, dysmorphic RBCs, WBCs | Bland: oval fat bodies, fatty casts; no RBC casts |
| Renal function | Often impaired (elevated creatinine) | Usually preserved early |
- Some diseases (MPGN, lupus nephritis, FSGS) can present with overlap features of both syndromes
Clinical features
Classic acute nephritic syndrome
- Hematuria "cola-colored," "tea-colored," or "smoky" urine (gross hematuria); or microscopic hematuria
- Edema periorbital (especially on waking), lower extremity; mild to moderate
- Hypertension from sodium/water retention and intravascular volume expansion; may be severe
- Oliguria reduced urine output (<400 mL/day in adults; <0.5 mL/kg/hr in children)
- Proteinuria present but usually subnephrotic
- Malaise, fatigue, anorexia, nausea
- Flank or abdominal pain (especially in children)
- Onset is often abrupt (days to 1-2 weeks)
Post-streptococcal glomerulonephritis (PSGN) — the prototype
- Most common cause in children (ages 5-12 years); declining incidence in developed countries[2]
- Latent period 1-2 weeks after pharyngitis; 3-6 weeks after skin infection (pyoderma/impetigo)
- Not present during the infection — symptoms appear after a latent period (distinguishes from IgA nephropathy, which is synpharyngitic)
- Gross hematuria in >50% of cases; "smoky" or "cola-colored" urine
- Edema and hypertension from salt/water retention
- Low C3 complement (returns to normal within 6-8 weeks — failure to normalize suggests MPGN or C3 glomerulopathy)
- Usually self-limited in children (>95% recover completely); adults have worse prognosis
IgA nephropathy (Berger disease) — the most common GN worldwide
- Synpharyngitic hematuria: gross hematuria occurring within 1-2 days of an upper respiratory infection (NOT after a latent period — key distinction from PSGN)[3]
- Recurrent episodes of gross hematuria
- Between episodes: persistent microscopic hematuria ± proteinuria
- Normal complement levels (unlike PSGN)
- May overlap with Henoch-Schönlein purpura (IgA vasculitis) — systemic form with palpable purpura, arthritis, abdominal pain, and GN
Rapidly progressive glomerulonephritis (RPGN) — the EM emergency
- Defines >50% loss of renal function within 3 months
- Nephritic sediment + rapidly rising creatinine over days to weeks
- Pathologic hallmark: crescent formation in glomeruli on biopsy
- Three immunologic categories:
| Type | Mechanism | Classic disease | Key lab findings |
|---|---|---|---|
| Type I (anti-GBM) | Anti-glomerular basement membrane antibodies | Goodpasture syndrome (anti-GBM + pulmonary hemorrhage) | Anti-GBM antibodies positive; complement normal |
| Type II (immune complex) | Immune complex deposition | Lupus nephritis, PSGN (severe), IgA nephropathy, MPGN, endocarditis-related | ANA, anti-dsDNA (lupus); low complement (C3, C4); cryoglobulins |
| Type III (pauci-immune) | ANCA-associated vasculitis (minimal immune deposits) | Granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) | ANCA positive (c-ANCA/PR3 for GPA; p-ANCA/MPO for MPA); complement normal |
- RPGN is a true nephrology emergency — delay in treatment leads to irreversible ESKD
- Requires immediate nephrology consultation, renal biopsy, and aggressive immunosuppression ± plasma exchange
Pulmonary-renal syndrome
- Hemoptysis + nephritic syndrome = pulmonary-renal syndrome until proven otherwise
- Causes: Goodpasture syndrome (anti-GBM), GPA, MPA, lupus, cryoglobulinemia
- May present with diffuse alveolar hemorrhage (DAH): hemoptysis, dyspnea, bilateral infiltrates on CXR, dropping hemoglobin
- Life-threatening — requires ICU admission, urgent nephrology and pulmonology consultation
Differential diagnosis
By complement level (high-yield ED approach)
Low C3 (hypocomplementemic)
- Post-streptococcal GN (low C3; C4 normal or slightly low; normalizes by 6-8 weeks)
- Lupus nephritis (low C3 AND C4)
- MPGN / C3 glomerulopathy (persistently low C3)
- Endocarditis-associated GN (low C3; blood cultures positive)
- Cryoglobulinemic GN (low C3 and C4; hepatitis C associated)
Normal complement
- IgA nephropathy
- ANCA-associated vasculitis (GPA, MPA)
- Anti-GBM disease (Goodpasture)
- Henoch-Schönlein purpura
- Hereditary nephritis (Alport syndrome)
Non-glomerular causes of hematuria to exclude
- Urinary tract infection (positive urine culture; normal RBC morphology)
- Nephrolithiasis (flank pain; isomorphic RBCs; no casts)
- Trauma
- Urologic malignancy (adults; painless hematuria)
- Menstrual contamination
- Exercise-induced hematuria
Key to glomerular vs non-glomerular hematuria
- Glomerular dysmorphic RBCs (acanthocytes), RBC casts (virtually pathognomonic), proteinuria, brown/cola-colored urine, no clots
- Non-glomerular normal/isomorphic RBCs, no casts, pink/red urine, may have clots
Causes of Glomerulonephritis
- Poststreptococcal glomerulonephritis
- Hemolytic-uremic syndrome
- Henoch-Schonlein purpura
- IgA nephropathy
- Lupus nephritis
- Alport syndrome
- Goodpasture syndrome
- Paraneoplastic
Hyperkalemia
- Pseudohyperkalemia: hemolyzed specimen, prolonged tourniquet use prior to blood draw, thrombocytosis or leukocytosis
- Redistribution (shift from intracellular to extracellular space)
- Acidemia (see DKA)
- Cellular breakdown: see Rhabdomyolysis/Crush syndrome, electrical/thermal burn, hemolysis, see Tumor lysis syndrome
- Increased total body potassium
- Inadequate excretion: Acute/chronic renal failure, Addison's disease, type 4 RTA
- Drug-induced: potassium-sparing diuretic (spironolactone), angiotensin converting enzyme inhibitors (ACE-I), nonsteroidal anti-inflammatory drugs (NSAIDs)
- Excessive intake: diet, blood transfusion
- Other causes: succinylcholine, digitalis, beta-blockers
Evaluation
ED workup
- Urinalysis with microscopy the single most important test[4]
- RBC casts: virtually pathognomonic for glomerulonephritis
- Dysmorphic RBCs (acanthocytes — best seen with phase-contrast microscopy; >30% dysmorphic is highly specific for glomerular origin)
- Proteinuria (usually 1-3+ on dipstick)
- Sterile pyuria (WBCs without bacteria)
- BMP/CMP:
- Creatinine (elevated = impaired GFR; trending creatinine is critical for identifying RPGN)
- Potassium (hyperkalemia from impaired excretion — potentially life-threatening)
- Bicarbonate (metabolic acidosis)
- BUN (elevated; disproportionately elevated BUN:creatinine ratio in prerenal azotemia)
- CBC anemia (dilutional or from chronic disease); thrombocytopenia (TTP-HUS, SLE)
- Spot urine protein:creatinine ratio: quantifies proteinuria; helps distinguish nephritic (<3.5) from nephrotic (>3.5)
- Albumin usually near-normal (mildly low at most); if markedly low, consider nephrotic overlap
- Blood pressure frequently elevated; may be severely hypertensive
Targeted serologic workup (initiate from ED based on clinical suspicion)
| Test | What it identifies |
|---|---|
| C3, C4 complement | Low C3: PSGN, lupus, MPGN, endocarditis GN; Low C3+C4: lupus, cryoglobulinemia |
| ASO titer, anti-DNase B | Post-streptococcal GN (ASO elevated after pharyngitis; anti-DNase B after skin infection) |
| ANA, anti-dsDNA | Lupus nephritis |
| ANCA (c-ANCA/PR3, p-ANCA/MPO) | ANCA-associated vasculitis (GPA, MPA) |
| Anti-GBM antibodies | Goodpasture syndrome / anti-GBM disease |
| Blood cultures | Endocarditis-associated GN |
| Hepatitis B, C serologies | Hepatitis-associated GN, cryoglobulinemia, MPGN |
| Cryoglobulins | Cryoglobulinemic GN (often hepatitis C-associated) |
| HIV | HIV-associated nephropathy |
| Serum IgA | Elevated in ~50% of IgA nephropathy (nonspecific) |
Imaging
- Renal ultrasound assess kidney size (normal or enlarged in acute GN; small in chronic GN), exclude obstruction
- Chest X-ray if dyspnea (pulmonary edema, pulmonary hemorrhage/DAH), cough, hemoptysis
- CT head if hypertensive encephalopathy suspected (altered mental status, seizures, visual changes)
- Echocardiography if endocarditis suspected
Renal biopsy
- Not an ED procedure — arranged by nephrology
- Indicated for most adults with nephritic syndrome (PSGN in children with typical presentation usually does not require biopsy)
- Urgent biopsy indications: suspected RPGN, rapidly deteriorating renal function, unclear diagnosis
Management
Life-threatening emergencies (manage first)
Hypertensive emergency
- May present with encephalopathy, seizures, visual changes, pulmonary edema
- Salt and water restriction
- Loop diuretics furosemide 1-2 mg/kg IV (children) or 40-80 mg IV (adults) — first-line for volume-overload hypertension
- IV antihypertensives if diuretics insufficient: nicardipine infusion, labetalol, or hydralazine
- Avoid ACE inhibitors/ARBs in the acute setting with AKI and hyperkalemia (may worsen both)
- Target: gradual reduction; do not lower BP >25% in the first hour
Hyperkalemia
- Impaired renal excretion → dangerous hyperkalemia
- Manage per standard Hyperkalemia protocols: calcium gluconate (cardiac membrane stabilization), insulin + dextrose, albuterol, sodium bicarbonate, kayexalate/patiromer, dialysis if refractory
Pulmonary edema / volume overload
- IV furosemide (high-dose may be needed with impaired GFR)
- Oxygen, positive pressure ventilation (CPAP/BiPAP or intubation) if severe
- Fluid and sodium restriction
- Dialysis if refractory pulmonary edema unresponsive to diuretics
Pulmonary hemorrhage (pulmonary-renal syndrome)
- ICU admission
- Urgent nephrology and pulmonology consultation
- Plasma exchange (plasmapheresis): especially for anti-GBM disease (removes pathogenic antibodies)
- Pulse IV methylprednisolone (1 g daily for 3 days) ± cyclophosphamide — initiated by specialist
- Intubation and mechanical ventilation if significant hemorrhage/respiratory failure
- Type and crossmatch — transfuse for significant anemia from hemorrhage
General ED management of acute nephritic syndrome
- Fluid restriction limit to insensible losses + urine output
- Sodium restriction
- Loop diuretics for edema and hypertension
- Monitor urine output, blood pressure, electrolytes (especially potassium), creatinine q6-12 hours
- Treat underlying infection: antibiotics for endocarditis; note that PSGN treatment targets the complication (not the strep infection itself — the GN is post-infectious; antibiotics do not alter the course of GN but may eradicate ongoing streptococcal infection)
- Hold nephrotoxic medications: NSAIDs, aminoglycosides, contrast dye
Disease-specific treatment (nephrology-directed)
- PSGN supportive care; usually self-limited; antibiotics only to eradicate residual streptococcal infection
- Lupus nephritis corticosteroids ± mycophenolate mofetil or cyclophosphamide
- ANCA-associated vasculitis pulse steroids + cyclophosphamide or rituximab; plasma exchange for severe disease
- Anti-GBM disease plasma exchange + steroids + cyclophosphamide — true emergency; outcomes are time-dependent
- IgA nephropathy ACE inhibitor/ARB; immunosuppression for severe/progressive disease
- Endocarditis-associated GN treat the endocarditis; immunosuppression is contraindicated (would worsen infection)
Disposition
- Admit:
- Hypertensive emergency or severely elevated blood pressure
- Hyperkalemia
- Pulmonary edema or respiratory distress
- Rapidly rising creatinine (suspect RPGN) — urgent nephrology consult
- Pulmonary hemorrhage / pulmonary-renal syndrome — ICU
- Significant AKI (creatinine >2x baseline, oliguria, need for dialysis)
- New-onset nephritic syndrome in adults (most require biopsy and specialist evaluation)
- Consider discharge with close follow-up (48-72 hours):
- Child with classic PSGN presentation: mild edema + mild hypertension + stable renal function + no hyperkalemia + confirmed strep history
- Ensure nephrology or pediatric nephrology follow-up within 48-72 hours
- Return precautions: decreased urine output, worsening edema, headache, visual changes, seizures, difficulty breathing
- Always obtain nephrology consultation for: RPGN, pulmonary-renal syndrome, unclear diagnosis, adults with nephritic syndrome, renal failure requiring dialysis
See Also
- Nephrotic syndrome
- Focal segmental glomerulosclerosis
- Acute kidney injury
- Hyperkalemia
- Hypertensive emergency
- Post-streptococcal glomerulonephritis
- IgA nephropathy
- Lupus nephritis
- Goodpasture syndrome
- Henoch-Schönlein purpura
- Pulmonary embolism
External Links
- StatPearls — Nephritic Syndrome
- StatPearls — Glomerulonephritis
- PMC — Clinical Presentation & Management of Glomerular Diseases
- Medscape — Acute Glomerulonephritis Workup
- MSD Manual — Overview of Nephritic Syndrome
